scispace - formally typeset
B

Behrooz A. Akbarnia

Researcher at University of California, San Diego

Publications -  244
Citations -  11722

Behrooz A. Akbarnia is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Scoliosis & Medicine. The author has an hindex of 56, co-authored 224 publications receiving 9799 citations. Previous affiliations of Behrooz A. Akbarnia include Boston Children's Hospital & University of Southern California.

Papers
More filters
Journal ArticleDOI

Resting Pain Level as a Preoperative Predictor of Success With Indirect Decompression for Lumbar Spinal Stenosis: A Pilot Study:

TL;DR: Preoperative assessment of rest pain level in the supine position has a significant association with reduction in NRS leg and back scores in patients undergoing indirect decompression for lumbar spinal stenosis, and may successfully indicate which patients will be candidates for direct decompression with interbody fusion from an anterior or lateral approach.
Journal ArticleDOI

Paper #41: Two Year HRQOL Measures are Similar Between Magnetically-Controlled Growing Rod Patients and Traditional Growing Rod Patients

TL;DR: Despite having lower HRQoL domain scores pre-operatively, EOS patients treating with magnetically-controlled growing (MCGR) had similar EOSQ-24 domain scores after two years of treatment compared to patients treated with traditional growing rods (TGR).
Journal ArticleDOI

Clinically significant differences exist between curves in operative idiopathic early-onset scoliosis and adolescent idiopathic scoliosis.

TL;DR: Significant radiographical differences exist between operative IEOS and AIS curves and these findings suggest that younger patients may require more distal instrumentation and that proximal fixation techniques should consider the additional pullout forces created by the greater kyphosis.
Journal ArticleDOI

Can a bioactive interbody device reduce the cost burden of achieving lateral lumbar fusion?

TL;DR: The use of bioactive titanium interbody devices with a large surface footprint appears to result in a very high rate of effective fusion, despite the use of a small volume of low-cost biological material.